 | • レポートコード：D005-00763 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、腫瘍学生体内CROの世界市場を広く調査・分析し、今後の市場展望をまとめております。腫瘍学生体内CROの種類別市場規模（血液癌、固形癌、その他）、用途別市場規模（病院、リハビリセンター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Crown Bioscience、The Jackson Laboratory、Eurofins Scientific、Charles River Laboratory、EVOTEC、ICON Plc.、MI Bioresearch, Inc.、Covance、Taconic Biosciences、Wuxi AppTec.、Living Tumor Laboratory、Champion Oncology, Inc.、Xentech ・地域別グローバル市場分析 2015年-2020年 ・腫瘍学生体内CROの北米市場（アメリカ、カナダ、メキシコ） ・腫瘍学生体内CROのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・腫瘍学生体内CROのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・腫瘍学生体内CROの南米市場（ブラジル、アルゼンチン） ・腫瘍学生体内CROの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：血液癌、固形癌、その他 ・用途別分析：病院、リハビリセンター、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Oncology Based In-vivo CRO market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 889.4 million by 2025, from USD 750.4 million in 2019.
The Oncology Based In-vivo CRO market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Oncology Based In-vivo CRO market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Oncology Based In-vivo CRO market has been segmented into:
Blood cancer
Solid tumors
Other
By Application, Oncology Based In-vivo CRO has been segmented into:
Hospitals
Rehabilitation Centers
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oncology Based In-vivo CRO market presented in the report. This section sheds light on the sales growth of different regional and country-level Oncology Based In-vivo CRO markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oncology Based In-vivo CRO market.
The report offers in-depth assessment of the growth and other aspects of the Oncology Based In-vivo CRO market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Oncology Based In-vivo CRO Market Share Analysis
Oncology Based In-vivo CRO competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oncology Based In-vivo CRO sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oncology Based In-vivo CRO sales, revenue and market share for each player covered in this report.
The major players covered in Oncology Based In-vivo CRO are:
Crown Bioscience
The Jackson Laboratory
Eurofins Scientific
Charles River Laboratory
EVOTEC
ICON Plc.
MI Bioresearch, Inc.
Covance
Taconic Biosciences
Wuxi AppTec.
Living Tumor Laboratory
Champion Oncology, Inc.
Xentech
Table of Contents
1 Oncology Based In-vivo CRO Market Overview
1.1 Product Overview and Scope of Oncology Based In-vivo CRO
1.2 Classification of Oncology Based In-vivo CRO by Type
1.2.1 Global Oncology Based In-vivo CRO Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Oncology Based In-vivo CRO Revenue Market Share by Type in 2019
1.2.3 Blood cancer
1.2.4 Solid tumors
1.2.5 Other
1.3 Global Oncology Based In-vivo CRO Market by Application
1.3.1 Overview: Global Oncology Based In-vivo CRO Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Rehabilitation Centers
1.3.4 Others
1.4 Global Oncology Based In-vivo CRO Market by Regions
1.4.1 Global Oncology Based In-vivo CRO Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Oncology Based In-vivo CRO (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Oncology Based In-vivo CRO Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Oncology Based In-vivo CRO Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncology Based In-vivo CRO Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Oncology Based In-vivo CRO Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncology Based In-vivo CRO Status and Prospect (2015-2025)
2 Company Profiles
2.1 Crown Bioscience
2.1.1 Crown Bioscience Details
2.1.2 Crown Bioscience Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Crown Bioscience SWOT Analysis
2.1.4 Crown Bioscience Product and Services
2.1.5 Crown Bioscience Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
2.2 The Jackson Laboratory
2.2.1 The Jackson Laboratory Details
2.2.2 The Jackson Laboratory Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 The Jackson Laboratory SWOT Analysis
2.2.4 The Jackson Laboratory Product and Services
2.2.5 The Jackson Laboratory Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eurofins Scientific
2.3.1 Eurofins Scientific Details
2.3.2 Eurofins Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eurofins Scientific SWOT Analysis
2.3.4 Eurofins Scientific Product and Services
2.3.5 Eurofins Scientific Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
2.4 Charles River Laboratory
2.4.1 Charles River Laboratory Details
2.4.2 Charles River Laboratory Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Charles River Laboratory SWOT Analysis
2.4.4 Charles River Laboratory Product and Services
2.4.5 Charles River Laboratory Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
2.5 EVOTEC
2.5.1 EVOTEC Details
2.5.2 EVOTEC Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 EVOTEC SWOT Analysis
2.5.4 EVOTEC Product and Services
2.5.5 EVOTEC Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
2.6 ICON Plc.
2.6.1 ICON Plc. Details
2.6.2 ICON Plc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 ICON Plc. SWOT Analysis
2.6.4 ICON Plc. Product and Services
2.6.5 ICON Plc. Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
2.7 MI Bioresearch, Inc.
2.7.1 MI Bioresearch, Inc. Details
2.7.2 MI Bioresearch, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 MI Bioresearch, Inc. SWOT Analysis
2.7.4 MI Bioresearch, Inc. Product and Services
2.7.5 MI Bioresearch, Inc. Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
2.8 Covance
2.8.1 Covance Details
2.8.2 Covance Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Covance SWOT Analysis
2.8.4 Covance Product and Services
2.8.5 Covance Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
2.9 Taconic Biosciences
2.9.1 Taconic Biosciences Details
2.9.2 Taconic Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Taconic Biosciences SWOT Analysis
2.9.4 Taconic Biosciences Product and Services
2.9.5 Taconic Biosciences Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
2.10 Wuxi AppTec.
2.10.1 Wuxi AppTec. Details
2.10.2 Wuxi AppTec. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Wuxi AppTec. SWOT Analysis
2.10.4 Wuxi AppTec. Product and Services
2.10.5 Wuxi AppTec. Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
2.11 Living Tumor Laboratory
2.11.1 Living Tumor Laboratory Details
2.11.2 Living Tumor Laboratory Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Living Tumor Laboratory SWOT Analysis
2.11.4 Living Tumor Laboratory Product and Services
2.11.5 Living Tumor Laboratory Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
2.12 Champion Oncology, Inc.
2.12.1 Champion Oncology, Inc. Details
2.12.2 Champion Oncology, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Champion Oncology, Inc. SWOT Analysis
2.12.4 Champion Oncology, Inc. Product and Services
2.12.5 Champion Oncology, Inc. Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
2.13 Xentech
2.13.1 Xentech Details
2.13.2 Xentech Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Xentech SWOT Analysis
2.13.4 Xentech Product and Services
2.13.5 Xentech Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Oncology Based In-vivo CRO Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Oncology Based In-vivo CRO Players Market Share
3.2.2 Top 10 Oncology Based In-vivo CRO Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Oncology Based In-vivo CRO Revenue and Market Share by Regions
4.2 North America Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
4.3 Europe Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
4.5 South America Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
5 North America Oncology Based In-vivo CRO Revenue by Countries
5.1 North America Oncology Based In-vivo CRO Revenue by Countries (2015-2020)
5.2 USA Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
5.3 Canada Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
5.4 Mexico Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
6 Europe Oncology Based In-vivo CRO Revenue by Countries
6.1 Europe Oncology Based In-vivo CRO Revenue by Countries (2015-2020)
6.2 Germany Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
6.3 UK Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
6.4 France Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
6.5 Russia Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
6.6 Italy Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Oncology Based In-vivo CRO Revenue by Countries
7.1 Asia-Pacific Oncology Based In-vivo CRO Revenue by Countries (2015-2020)
7.2 China Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
7.3 Japan Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
7.4 Korea Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
7.5 India Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
8 South America Oncology Based In-vivo CRO Revenue by Countries
8.1 South America Oncology Based In-vivo CRO Revenue by Countries (2015-2020)
8.2 Brazil Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
8.3 Argentina Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Oncology Based In-vivo CRO by Countries
9.1 Middle East & Africa Oncology Based In-vivo CRO Revenue by Countries (2015-2020)
9.2 Saudi Arabia Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
9.3 UAE Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
9.4 Egypt Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
9.5 South Africa Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Oncology Based In-vivo CRO Revenue and Market Share by Type (2015-2020)
10.2 Global Oncology Based In-vivo CRO Market Forecast by Type (2019-2024)
10.3 Blood cancer Revenue Growth Rate (2015-2025)
10.4 Solid tumors Revenue Growth Rate (2015-2025)
10.5 Other Revenue Growth Rate (2015-2025)
11 Global Oncology Based In-vivo CRO Market Segment by Application
11.1 Global Oncology Based In-vivo CRO Revenue Market Share by Application (2015-2020)
11.2 Oncology Based In-vivo CRO Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Rehabilitation Centers Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Oncology Based In-vivo CRO Market Size Forecast (2021-2025)
12.1 Global Oncology Based In-vivo CRO Market Size Forecast (2021-2025)
12.2 Global Oncology Based In-vivo CRO Market Forecast by Regions (2021-2025)
12.3 North America Oncology Based In-vivo CRO Revenue Market Forecast (2021-2025)
12.4 Europe Oncology Based In-vivo CRO Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Oncology Based In-vivo CRO Revenue Market Forecast (2021-2025)
12.6 South America Oncology Based In-vivo CRO Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Oncology Based In-vivo CRO Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Oncology Based In-vivo CRO Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oncology Based In-vivo CRO by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oncology Based In-vivo CRO Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Oncology Based In-vivo CRO Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Crown Bioscience Corporate Information, Location and Competitors
Table 6. Crown Bioscience Oncology Based In-vivo CRO Major Business
Table 7. Crown Bioscience Oncology Based In-vivo CRO Total Revenue (USD Million) (2017-2018)
Table 8. Crown Bioscience SWOT Analysis
Table 9. Crown Bioscience Oncology Based In-vivo CRO Product and Solutions
Table 10. Crown Bioscience Oncology Based In-vivo CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. The Jackson Laboratory Corporate Information, Location and Competitors
Table 12. The Jackson Laboratory Oncology Based In-vivo CRO Major Business
Table 13. The Jackson Laboratory Oncology Based In-vivo CRO Total Revenue (USD Million) (2018-2019)
Table 14. The Jackson Laboratory SWOT Analysis
Table 15. The Jackson Laboratory Oncology Based In-vivo CRO Product and Solutions
Table 16. The Jackson Laboratory Oncology Based In-vivo CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Eurofins Scientific Corporate Information, Location and Competitors
Table 18. Eurofins Scientific Oncology Based In-vivo CRO Major Business
Table 19. Eurofins Scientific Oncology Based In-vivo CRO Total Revenue (USD Million) (2017-2018)
Table 20. Eurofins Scientific SWOT Analysis
Table 21. Eurofins Scientific Oncology Based In-vivo CRO Product and Solutions
Table 22. Eurofins Scientific Oncology Based In-vivo CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Charles River Laboratory Corporate Information, Location and Competitors
Table 24. Charles River Laboratory Oncology Based In-vivo CRO Major Business
Table 25. Charles River Laboratory Oncology Based In-vivo CRO Total Revenue (USD Million) (2017-2018)
Table 26. Charles River Laboratory SWOT Analysis
Table 27. Charles River Laboratory Oncology Based In-vivo CRO Product and Solutions
Table 28. Charles River Laboratory Oncology Based In-vivo CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. EVOTEC Corporate Information, Location and Competitors
Table 30. EVOTEC Oncology Based In-vivo CRO Major Business
Table 31. EVOTEC Oncology Based In-vivo CRO Total Revenue (USD Million) (2017-2018)
Table 32. EVOTEC SWOT Analysis
Table 33. EVOTEC Oncology Based In-vivo CRO Product and Solutions
Table 34. EVOTEC Oncology Based In-vivo CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. ICON Plc. Corporate Information, Location and Competitors
Table 36. ICON Plc. Oncology Based In-vivo CRO Major Business
Table 37. ICON Plc. Oncology Based In-vivo CRO Total Revenue (USD Million) (2017-2018)
Table 38. ICON Plc. SWOT Analysis
Table 39. ICON Plc. Oncology Based In-vivo CRO Product and Solutions
Table 40. ICON Plc. Oncology Based In-vivo CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. MI Bioresearch, Inc. Corporate Information, Location and Competitors
Table 42. MI Bioresearch, Inc. Oncology Based In-vivo CRO Major Business
Table 43. MI Bioresearch, Inc. Oncology Based In-vivo CRO Total Revenue (USD Million) (2017-2018)
Table 44. MI Bioresearch, Inc. SWOT Analysis
Table 45. MI Bioresearch, Inc. Oncology Based In-vivo CRO Product and Solutions
Table 46. MI Bioresearch, Inc. Oncology Based In-vivo CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Covance Corporate Information, Location and Competitors
Table 48. Covance Oncology Based In-vivo CRO Major Business
Table 49. Covance Oncology Based In-vivo CRO Total Revenue (USD Million) (2017-2018)
Table 50. Covance SWOT Analysis
Table 51. Covance Oncology Based In-vivo CRO Product and Solutions
Table 52. Covance Oncology Based In-vivo CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Taconic Biosciences Corporate Information, Location and Competitors
Table 54. Taconic Biosciences Oncology Based In-vivo CRO Major Business
Table 55. Taconic Biosciences Oncology Based In-vivo CRO Total Revenue (USD Million) (2017-2018)
Table 56. Taconic Biosciences SWOT Analysis
Table 57. Taconic Biosciences Oncology Based In-vivo CRO Product and Solutions
Table 58. Taconic Biosciences Oncology Based In-vivo CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Wuxi AppTec. Corporate Information, Location and Competitors
Table 60. Wuxi AppTec. Oncology Based In-vivo CRO Major Business
Table 61. Wuxi AppTec. Oncology Based In-vivo CRO Total Revenue (USD Million) (2017-2018)
Table 62. Wuxi AppTec. SWOT Analysis
Table 63. Wuxi AppTec. Oncology Based In-vivo CRO Product and Solutions
Table 64. Wuxi AppTec. Oncology Based In-vivo CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Living Tumor Laboratory Corporate Information, Location and Competitors
Table 66. Living Tumor Laboratory Oncology Based In-vivo CRO Major Business
Table 67. Living Tumor Laboratory Oncology Based In-vivo CRO Total Revenue (USD Million) (2017-2018)
Table 68. Living Tumor Laboratory SWOT Analysis
Table 69. Living Tumor Laboratory Oncology Based In-vivo CRO Product and Solutions
Table 70. Living Tumor Laboratory Oncology Based In-vivo CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Champion Oncology, Inc. Corporate Information, Location and Competitors
Table 72. Champion Oncology, Inc. Oncology Based In-vivo CRO Major Business
Table 73. Champion Oncology, Inc. Oncology Based In-vivo CRO Total Revenue (USD Million) (2017-2018)
Table 74. Champion Oncology, Inc. SWOT Analysis
Table 75. Champion Oncology, Inc. Oncology Based In-vivo CRO Product and Solutions
Table 76. Champion Oncology, Inc. Oncology Based In-vivo CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Xentech Corporate Information, Location and Competitors
Table 78. Xentech Oncology Based In-vivo CRO Major Business
Table 79. Xentech Oncology Based In-vivo CRO Total Revenue (USD Million) (2017-2018)
Table 80. Xentech SWOT Analysis
Table 81. Xentech Oncology Based In-vivo CRO Product and Solutions
Table 82. Xentech Oncology Based In-vivo CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Oncology Based In-vivo CRO Revenue (Million USD) by Players (2015-2020)
Table 84. Global Oncology Based In-vivo CRO Revenue Share by Players (2015-2020)
Table 85. Global Oncology Based In-vivo CRO Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Oncology Based In-vivo CRO Revenue Market Share by Regions (2015-2020)
Table 87. North America Oncology Based In-vivo CRO Revenue by Countries (2015-2020)
Table 88. North America Oncology Based In-vivo CRO Revenue Market Share by Countries (2015-2020)
Table 89. Europe Oncology Based In-vivo CRO Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Oncology Based In-vivo CRO Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Oncology Based In-vivo CRO Revenue by Countries (2015-2020)
Table 92. South America Oncology Based In-vivo CRO Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Oncology Based In-vivo CRO Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Oncology Based In-vivo CRO Revenue Market Share by Countries (2015-2020)
Table 95. Global Oncology Based In-vivo CRO Revenue (Million USD) by Type (2015-2020)
Table 96. Global Oncology Based In-vivo CRO Revenue Share by Type (2015-2020)
Table 97. Global Oncology Based In-vivo CRO Revenue Forecast by Type (2021-2025)
Table 98. Global Oncology Based In-vivo CRO Revenue by Application (2015-2020)
Table 99. Global Oncology Based In-vivo CRO Revenue Share by Application (2015-2020)
Table 100. Global Oncology Based In-vivo CRO Revenue Forecast by Application (2021-2025)
Table 101. Global Oncology Based In-vivo CRO Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Oncology Based In-vivo CRO Picture
Figure 2. Global Oncology Based In-vivo CRO Revenue Market Share by Type in 2019
Figure 3. Blood cancer Picture
Figure 4. Solid tumors Picture
Figure 5. Other Picture
Figure 6. Oncology Based In-vivo CRO Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Rehabilitation Centers Picture
Figure 9. Others Picture
Figure 10. Global Oncology Based In-vivo CRO Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Oncology Based In-vivo CRO Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Oncology Based In-vivo CRO Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Oncology Based In-vivo CRO Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Oncology Based In-vivo CRO Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Oncology Based In-vivo CRO Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Oncology Based In-vivo CRO Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Oncology Based In-vivo CRO Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Oncology Based In-vivo CRO Revenue Market Share in 2019
Figure 19. Global Top 10 Players Oncology Based In-vivo CRO Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Oncology Based In-vivo CRO Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Oncology Based In-vivo CRO Revenue Market Share by Regions (2015-2020)
Figure 23. Global Oncology Based In-vivo CRO Revenue Market Share by Regions in 2018
Figure 24. North America Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 25. Europe Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 27. South America Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 29. North America Oncology Based In-vivo CRO Revenue Market Share by Countries (2015-2020)
Figure 30. North America Oncology Based In-vivo CRO Revenue Market Share by Countries in 2019
Figure 31. USA Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 32. Canada Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 34. Europe Oncology Based In-vivo CRO Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Oncology Based In-vivo CRO Revenue Market Share by Countries in 2019
Figure 36. Germany Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 37. UK Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 38. France Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 39. Russia Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 40. Italy Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Oncology Based In-vivo CRO Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Oncology Based In-vivo CRO Revenue Market Share by Countries in 2019
Figure 43. China Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 44. Japan Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 45. Korea Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 46. India Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 48. South America Oncology Based In-vivo CRO Revenue Market Share by Countries (2015-2020)
Figure 49. South America Oncology Based In-vivo CRO Revenue Market Share by Countries in 2019
Figure 50. Brazil Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Oncology Based In-vivo CRO Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Oncology Based In-vivo CRO Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 55. UAE Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Oncology Based In-vivo CRO Revenue and Growth Rate (2015-2020)
Figure 58. Global Oncology Based In-vivo CRO Revenue Share by Type (2015-2020)
Figure 59. Global Oncology Based In-vivo CRO Revenue Share by Type in 2019
Figure 60. Global Oncology Based In-vivo CRO Market Share Forecast by Type (2021-2025)
Figure 61. Global Blood cancer Revenue Growth Rate (2015-2020)
Figure 62. Global Solid tumors Revenue Growth Rate (2015-2020)
Figure 63. Global Other Revenue Growth Rate (2015-2020)
Figure 64. Global Oncology Based In-vivo CRO Revenue Share by Application (2015-2020)
Figure 65. Global Oncology Based In-vivo CRO Revenue Share by Application in 2019
Figure 66. Global Oncology Based In-vivo CRO Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Rehabilitation Centers Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Oncology Based In-vivo CRO Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Oncology Based In-vivo CRO Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Oncology Based In-vivo CRO Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Oncology Based In-vivo CRO Revenue Market Forecast (2021-2025)
Figure 74. Europe Oncology Based In-vivo CRO Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Oncology Based In-vivo CRO Revenue Market Forecast (2021-2025)
Figure 76. South America Oncology Based In-vivo CRO Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Oncology Based In-vivo CRO Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
In Vivoイメージシステム用顕微鏡の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global In Vivo Imaging System Microscopes market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The In Vivo Im…- 腫瘍用注射薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oncology Injection Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oncology Injection Dr…
- 免疫腫瘍薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Immuno-oncology Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.1% in the forecast period of 2020 to 2025 and will expected to reach USD 73080 million by 2025, from USD 53550 million in 2019. The Immuno-oncology …
- ジェネリック腫瘍滅菌注射の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Generic Oncology Sterile Injectable market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.2% in the forecast period of 2020 to 2025 and will expected to reach USD 12600 million by 2025, from USD 9912.3 million in 2019. The G…
- 振動プラットフォームの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Vibration Platform market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Vibration Platform market …